TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2023
Back to search
Official data from USPTO
GENOMICARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/24/2023
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
10/28/2020
Registration date
02/01/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/01/2022
Last transaction
06/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/07/2017
First use in commerce
06/16/2020
Drawing code
5
Owner type
03
Owner location
Boston, MA, US
Examiner
SULLIVAN, JOHN C
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "GENOMICARE" in stylized block letters.
Holders and representatives
Holders
GenomiCare, Inc.
Representatives
Ashley Bennett Ewald Taft Stettinius & Hollister LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
19 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/01/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/29/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/28/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/28/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/27/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/22/2021
IUAF
USE AMENDMENT FILED
11/30/2021
EISU
TEAS STATEMENT OF USE RECEIVED
11/30/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2021
DOCK
ASSIGNED TO EXAMINER
03/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2020
NWAP
NEW APPLICATION ENTERED
11/01/2020
Continuous trademark protection
Get notified about every new filing that threatens GENOMICARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.